1LY7
| The solution structure of the the c-terminal domain of frataxin, the protein responsible for friedreich ataxia | Descriptor: | frataxin | Authors: | Musco, G, Stier, G, Kolmerer, B, Adinolfi, S, Martin, S, Frenkiel, T, Gibson, T, Pastore, A. | Deposit date: | 2002-06-07 | Release date: | 2002-06-26 | Last modified: | 2022-12-21 | Method: | SOLUTION NMR | Cite: | Towards a structural understanding of Friedreich's
ataxia: the solution structure of frataxin Structure Fold.Des., 8, 2000
|
|
1ZTA
| THE SOLUTION STRUCTURE OF A LEUCINE-ZIPPER MOTIF PEPTIDE | Descriptor: | LEUCINE ZIPPER MONOMER | Authors: | Saudek, V, Pastore, A, Castiglione Morelli, M.A, Frank, R, Gausepohl, H, Gibson, T. | Deposit date: | 1990-10-11 | Release date: | 1993-04-15 | Last modified: | 2022-03-02 | Method: | SOLUTION NMR | Cite: | The solution structure of a leucine-zipper motif peptide. Protein Eng., 4, 1991
|
|
5UOR
| Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure | Descriptor: | 6-{[(2S)-4-methylmorpholin-2-yl]methoxy}-2-{6-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]pyridin-2-yl}-2,3-dihydro-1H-isoindol-1-one, Mitogen-activated protein kinase kinase kinase 5, SULFATE ION | Authors: | Dougan, D.R. | Deposit date: | 2017-02-01 | Release date: | 2017-06-07 | Last modified: | 2024-03-06 | Method: | X-RAY DIFFRACTION (2.75 Å) | Cite: | Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure. ACS Med Chem Lett, 8, 2017
|
|
5UP3
| |
5UOX
| |